The use of an imaging technique such as gamma scintigraphy to follow t
he behaviour of a formulation in the gastrointestinal tract is widely
employed in the development of new therapeutic concepts. Such studies
are facilitated by the availability of suitable radiolabels, incorpora
ted into the formulation during manufacture. The range of labels for l
ipophilic excipients is very limited, although new brain-imaging agent
s may offer interesting possibilities. The use of alternative imaging
modalities such as magnetic resonance imaging should also be considere
d, The difference in the T-1- or T-2-weighted signal from the oil agai
nst the aqueous contents provides a method of visualising an oil-based
formulation in vivo without any modification to the formulation. This
article reviews approaches in the search for suitable techniques for
is vivo imaging of oral formulations containing a high proportion of o
il.